Richard Daly is Director, President, and Chief Executive Officer of Catalyst Pharmaceuticals, Inc. (CPRX). The company reported total compensation of $7,774,160 for fiscal year 2024.
| Salary | $750,000 |
|---|---|
| Bonus | $590,625 |
| Stock awards | $1,267,601 |
| Option awards | $5,070,830 |
| Non-equity incentive plan | $0 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $95,104 |
| Total | $7,774,160 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Catalyst Pharmaceuticals, Inc. filed April 11, 2025, accession 0001193125-25-079097.
| Peer-group chief executive median | $10,278,620 |
|---|---|
| Difference from that median | $-2,504,460 |
| Percentile within the disclosed peer group | 13th |
| Peers with a disclosed figure | 15 |
Medians and percentiles are computed across the peer group Catalyst Pharmaceuticals, Inc. discloses in its own compensation disclosure.
| Named executive officer | Role | FY2024 total |
|---|---|---|
| Richard Daly this page | Director, President, and Chief Executive Officer | $7,774,160 |
| Michael Kalb | Executive Vice President, Treasurer, and Chief Financial Officer | $6,180,936 |
| Steven Miller | Executive Vice President, Chief Operating Officer, and Chief Scientific Officer | $3,545,774 |
| Jeffrey Del Carmen | Executive Vice President, Chief Commercial Officer | $2,638,127 |
| Preethi Sundaram | Chief Strategy Officer | $2,528,555 |
The company's named executive officers for fiscal year 2024, and what it reported for each. See the full Catalyst Pharmaceuticals, Inc. compensation brief.
Richard Daly's compensation sits inside Catalyst Pharmaceuticals, Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.
The Catalyst Pharmaceuticals, Inc. (CPRX) compensation brief